Search

Your search keyword '"Verma, Chandra S."' showing total 778 results

Search Constraints

Start Over You searched for: Author "Verma, Chandra S." Remove constraint Author: "Verma, Chandra S."
778 results on '"Verma, Chandra S."'

Search Results

2. PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression

3. Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists

4. Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilities

8. Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

9. High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

11. List of contributors

27. Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation

28. A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma

29. Molecular descriptors suggest stapling as a strategy for optimizing membrane permeability of cyclic peptides.

31. Mechanisms of biased agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor.

32. A high‐throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell‐based assays

33. Data from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

34. Supplementary Figures from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

35. Supplementary Tables from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

36. Design-Rules for Stapled Alpha-Helical Peptides with On-Target In Vivo Activity: Application to Mdm2/X dual antagonists

43. Design-Rules for Stapled Alpha-Helical Peptides with On-Target In Vivo Activity: Application to Mdm2/X dual antagonists

Catalog

Books, media, physical & digital resources